Today in this blog we will try to know Glaxosmithkline Pharmaceuticals Share Price Target 2025, 2026, 2027, To 2030 In this blog we are going to analyze the stock Glaxosmithkline Pharmaceuticals Ltd of the Pharmaceuticals sector. In this blog we will do all the research of the company for you like what does the company do? How can the performance of the company be for 5 years? Future status of the company? You will find information about all this research in this blog.
After reading this blog, you will also get to know about the technical analysis along with fundamentals about Glaxosmithkline Pharmaceuticals Ltd. From which you can find out whether you should invest in this company or not, so let’s try to know the company.
About Glaxosmithkline Pharmaceuticals Ltd
GSK operates as a global biopharmaceutical company whose purpose is to “unite science, technology and talent to work together to tackle disease.” Their business model is centered on: Research and Development, Global reach, Diversified portfolio, Partnerships
GlaxoSmithKline Pharmaceuticals Limited in India was founded on November 13, 1924 and is headquartered in Mumbai, Maharashtra, India.
| Company Name | Glaxosmithkline Pharmaceuticals Ltd |
| Market Cap | ₹ 42,976 Cr. |
| P/E | 50.3 |
| ROE (Return on equity) | 37.3 % |
| ROCE (Return on Capital Employed ) | 51.3 % |
| 52 Week High (21-Aug-2024) | ₹ 3,088 |
| 52 Week Low (15-Apr-2024) | ₹1,842.05 |
| DIV. YIELD | 1.26 % |
| Date of Listing | 15-Dec-2000 |
Glaxosmithkline Pharmaceuticals last 5 Year Performance
If we talk about the returns of Glaxosmithkline Pharmaceuticals Ltd share in the last few years, then the company has given 176.41% returns to its investors in the last 1 year ( Feb 2024 – Feb 2025). And if we talk about 5 Year’s Returns, then it has given 425.09% returns to its investors.
| 3 Month Returns | 15.10% |
| 1 Year’s Returns | 176.41% |
| 5 Year’s Returns | 425.09% |
| Sales growth 3 Years | 20.5 % |
| Sales growth 5 Years | 12.1 % |
| Return over 3years | 87.8 % |
| Return over 5years | 40.2 % |
Read this also:- Morepen Lab Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Glaxosmithkline Pharmaceuticals Share Price Target 2025-2030
| Year | Target 1 | Target 2 |
| 2025 | ₹3000 | ₹3200 |
| 2026 | ₹3200 | ₹3800 |
| 2027 | ₹3500 | ₹4500 |
| 2028 | ₹4000 | ₹5500 |
| 2029 | ₹4500 | ₹6000 |
| 2030 | ₹5000 | ₹7000 |
Glaxosmithkline Pharmaceuticals Share Price Target 2025
Talking about the Glaxosmithkline Pharmaceuticals Share Price Target 2025, our analysis has said that this stock can remain between ₹ 3000 and ₹ 3200 in 2025.
These targets are given after looking at the data of the past history of the stock. In this, fundamental analysis has been done along with technical analysis.
| Target 1 | Target 2 |
| ₹ 3000 | ₹ 3200 |
Gsk Pharma Share Price Target 2026
If the demand in this industry and the sales of this company see an increase, then as per our research the share price of Glaxosmithkline Pharmaceuticals Ltd may remain between ₹ 3200 and ₹ 3800 by 2026.
| Target 1 | Target 2 |
| ₹ 3200 | ₹ 3800 |
Read this also:- ITI Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Gsk India Share Price Target 2027
These share targets have been derived by looking at the company’s past performance. If the company’s performance remains good, then according to our analysts, the target for Glaxosmithkline Pharmaceuticals shares in 2027 can be between ₹ 3500 and ₹ 4500.
| Target 1 | Target 2 |
| ₹ 3500 | ₹ 4500 |
Glaxosmithkline Pharmaceuticals Share Price Target 2028
By analyzing the trend and stock of the last few years, it is known that if we talk about the target of Glaxosmithkline Pharmaceuticals share price in 2028, then it can be between ₹ 4000 and ₹ 5500.
| Target 1 | Target 2 |
| ₹ 4000 | ₹ 5500 |
Glaxosmithkline Pharmaceuticals Share Price Target 2029
Looking at the history of the last 5 years and the fundamental analysis of the stock, it seems that in the coming years i.e. if we talk about the target of Glaxosmithkline Pharmaceuticals Share in 2029, then ₹ 4500 and ₹6000 can be seen.
| Target 1 | Target 2 |
| ₹ 4500 | ₹ 6000 |
Glaxosmithkline Pharmaceuticals Share Price Target 2030
The price of Glaxosmithkline Pharmaceuticals stock can remain between ₹5000 to ₹7000 by 2030. This price can also go up or down, this price is told by analyzing the stock data of the last 5 years.
The price of the company’s stock depends on how the company performs in the coming time. You must take the help of your financial advisor before investing.
| Target 1 | Target 2 |
| ₹5000 | ₹7000 |
Glaxosmithkline Pharmaceuticals Promoters Holding
Friends, before investing in any company, it is very important to see the holding of the company’s promoters because from this we get an idea that if the promoters of the company have maintained their holding and are not selling it, then the company is performing well and can perform well.
It is said that it is not good if promoter’s holding is less in any company but it is said that if the holdings of FIIs and DIIs are increasing then it is good.
If we talk about the promoters’ holding in this company, it is 75.00% You will see below who else has a stake in it.
| Mar 2022 | Mar 2023 | Mar 2024 | Dec 2024 | |
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% |
| FIIs | 2.18% | 2.28% | 3.48% | 4.50% |
| DIIs | 10.73% | 10.31% | 7.90% | 7.30% |
| Public | 12.09% | 12.43% | 13.62% | 13.21% |
Glaxosmithkline Pharmaceuticals Peer Companies
- Abbott India
- Glaxosmi. Pharma
- Pfizer
- Astrazeneca Phar
- Sanofi India
- Sanofi Consumer
- P & G Health Ltd
Conclusion
We hope that you have got all the information about Glaxosmithkline Pharmaceuticals Share Price Target 2025, 2026, 2027, To 2030 properly and how did you like our blog, please tell us by commenting and also tell us what are your thoughts about Glaxosmithkline Pharmaceuticals Ltd. Do share this article with your friends.
Frequently Asked Questions FAQ’S
How much debt does Glaxosmithkline Pharmaceuticals have?
As of today when we are posting this blog, Glaxosmithkline Pharmaceuticals has a debt of ₹ 14.8 Cr.
What does Glaxosmithkline Pharmaceuticals Ltd do?
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.
Read this also:- Sundaram Finance Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Disclaimer : The information presented in this article is for educational and informational purposes only. We do not recommend buying or selling stocks. These predictions are based on our research and technical data, any uncertainty in the market may affect the stock price, so investors should do their own research before making investment decisions. We will not be responsible for any loss or damage caused by the use of this article.